Abstract
The 5-HT7 receptor (5-HT7R), characterized in 1993, is the most recently described member of the serotonin family. Since its discovery, 5-HT7R has been the subject of extensive research due to its widespread distribution in the brain, suggestive of multiple central roles. The focus of this review is to illustrate the literature concerning developments of the last few years (2007-2010) towards the discovery of novel and selective 5-HT7R ligands, agonists, antagonist and inverse agonists.
Keywords: 5-HT7R, 5-HT7 ligands, agonists, antagonists, G protein-coupled receptors, serotonin, serotonin receptor subtypes, CNS, PNS, GPCRs
Mini-Reviews in Medicinal Chemistry
Title: Latest Advances Towards the Discovery of 5-HT7 Receptor Ligands
Volume: 11 Issue: 13
Author(s): V. Pittala and D. Pittala
Affiliation:
Keywords: 5-HT7R, 5-HT7 ligands, agonists, antagonists, G protein-coupled receptors, serotonin, serotonin receptor subtypes, CNS, PNS, GPCRs
Abstract: The 5-HT7 receptor (5-HT7R), characterized in 1993, is the most recently described member of the serotonin family. Since its discovery, 5-HT7R has been the subject of extensive research due to its widespread distribution in the brain, suggestive of multiple central roles. The focus of this review is to illustrate the literature concerning developments of the last few years (2007-2010) towards the discovery of novel and selective 5-HT7R ligands, agonists, antagonist and inverse agonists.
Export Options
About this article
Cite this article as:
Pittala V. and Pittala D., Latest Advances Towards the Discovery of 5-HT7 Receptor Ligands, Mini-Reviews in Medicinal Chemistry 2011; 11 (13) . https://dx.doi.org/10.2174/138955711797655353
DOI https://dx.doi.org/10.2174/138955711797655353 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Urokinase Receptor Interactome
Current Pharmaceutical Design Screening of Some Novel 4, 5 Disubstituted 1, 2, 4-Triazole-3-thiones for Anticonvulsant Activity
Central Nervous System Agents in Medicinal Chemistry Cardiac Biomarkers in Stroke, Alzheimer’s Disease, and Other Dementia. Are They of Use? A Brief Overview of Data from Recent Investigations
CNS & Neurological Disorders - Drug Targets Use of Non-steroidal Anti-inflammatory Drugs in Pregnancy: Impact on the Fetus and Newborn
Current Drug Metabolism Diagnostic Boundaries of Autism Disorder Vs Pervasive Developmental Disorder Nos Comparative Observational Study and Literature Review
Current Clinical Pharmacology An Insight into the New Anticonvulsant Agents
Current Topics in Medicinal Chemistry Action Mechanisms of Chinese Herbal Compound at the Molecular Level
Letters in Drug Design & Discovery <i>Dichrostachys cinerea</i>: Ethnomedicinal Uses, Phytochemistry and Pharmacological Activities - A Review
The Natural Products Journal Recent Advances in Nanoneurology for Drug Delivery to the Brain
Current Nanoscience 5-HT3 Receptors: A Potential Therapeutic Target for Epilepsy
Current Neuropharmacology Role of the GABAA Receptor in Anxiety: Evidence from animal models, molecular and clinical psychopharmacology, and brain imaging studies
Current Neuropharmacology Biodistribution Processes as Underestimated Confounders in Translational Stroke Research
Current Medicinal Chemistry Targeting Oxidative Stress Component in the Therapeutics of Epilepsy
Current Topics in Medicinal Chemistry Kv7 Channels: Function, Pharmacology and Channel Modulators
Current Topics in Medicinal Chemistry Functional Connectivity in a Rat Model of Alzheimer's Disease During a Working Memory Task
Current Alzheimer Research Towards a Unified Theory of Calmodulin Regulation (Calmodulation) of Voltage-Gated Calcium and Sodium Channels
Current Molecular Pharmacology New Therapeutic Strategies in Perinatal Stroke
Current Drug Targets - CNS & Neurological Disorders Natural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy
Current Neuropharmacology Physiology and Pharmacology of Two-Pore Domain Potassium Channels
Current Pharmaceutical Design Modeling Rett Syndrome Using Human Induced Pluripotent Stem Cells
CNS & Neurological Disorders - Drug Targets